Trimi vs Henry Meds

Both sell tirzepatide. Trimi costs $125 a month and Henry Meds costs $449, a difference of $324 a month or about $3,888 a year. The desk reads it as follows.

Trimi is lowest flat price with named pharmacies. Henry Meds is sublingual and oral formats. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.

Advert against bill. Trimi advertises $125 and bills $125; Henry Meds advertises $399 and bills $449. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.

Side by side

Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.

The split

They differ on 4 of the 7 things we track, and behave the same on the other 3. The differences are what the price gap is actually buying.

What each puts on the record: Trimi

• Compounded tirzepatide advertised at $125/month on the annual plan.
• Compounded semaglutide advertised at $99/month on the annual plan.
• Price is the same at every prescribed dose.
• One flat charge covers medication, clinician visits, check-ins and free overnight shipping; no separate membership.
• Names its compounding pharmacies publicly: VialsRx (Texas Board of Pharmacy #35264) and GreenwichRx, with a certificate of analysis available on request.
• Medical oversight via Arora Health, a 50-state network led by Dr. Sean Arora, MD.
• Advertises a six-month money-back promise subject to terms.

Where it wins: The cheapest verified flat rate for compounded tirzepatide in this comparison. Watch for: Both headline prices are annual-plan rates. Confirm the month-to-month figure and the refund terms before prepaying twelve months.

What each puts on the record: Henry Meds

• Injectable tirzepatide listed at $399 for the first month and $449/month recurring.
• Oral tirzepatide tablets listed at $299 first month, $349/month recurring.
• Compounded semaglutide injection around $297/month; sublingual around $249/month with a $179/month tier.
• Three-month oral tirzepatide supply $1,047, or $891 paid in full.
• Three-month oral semaglutide supply $747, or $537 paid in full.
• Advertising states pricing "starts at $179/month", which corresponds to the lowest sublingual tier.

Where it wins: No membership fee layered on top of medication. Watch for: The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.

In each one’s favour

Trimi.

• The cheapest verified flat rate for compounded tirzepatide in this comparison.
• Names its pharmacies with a licence number and offers a certificate of analysis — almost nobody else in this market does.

Henry Meds.

• No membership fee layered on top of medication.
• Real choice of sublingual, oral tablet and injection.

How they score

Trimi scores higher overall at 4.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.

The desk’s call

• Pick Trimi if cost is the binding constraint. Over a year the gap is about $3,888, which is real money for the same class of medication.
• Pick Henry Meds if what it does better matters to you — no membership fee layered on top of medication.
• If sourcing matters, note that Trimi publishes which pharmacy compounds its medication and Henry Meds does not.

The verdict

On the board, Trimi at $125 a month is the more defensible choice on arithmetic alone. Henry Meds earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Trimi and Henry Meds.

How they sit against everyone else